Skip to main content
Back to Felicis

Felicis's Biotechnology Portfolio

Browse 21 Biotechnology companies funded by Felicis. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
21
Total Funding in Biotechnology
$971.2M

Biotechnology Portfolio Companies (21)

Export
Biotechnology

Cellino is building an ultra-scalable biomanufacturing technology stack for personalized cell, tissue, and organ replacement therapies.

Cambridge, United States
September 2024
$25.0M
Grant

Founder Contacts

30,000+ verified contacts

AnalyticsBig DataBiotechnologyData VisualizationHealth CareMedical

Intelligence to Accelerate Human Health

San Francisco, United States
June 2022
$60.0M
Series C

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMachine LearningPharmaceuticalSoftwareTherapeutics

Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.

Salt Lake City, United States
June 2024
$200.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyMedical

General Proximity is a pioneering future-oriented proximity medicine that envisions the future of medicine.

San Francisco, United States
May 2026
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

ProteinQure is a biotech company that designs peptide-based therapeutics and drug delivery systems using AI.

Toronto, Canada
May 2026
$1.8M
Grant

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyInformation Technology

Genesis Therapeutics unifies AI and biotech to accelerate the discovery of new medicines.

South San Francisco, United States
May 2026
$40.0M
Corporate Round

Founder Contacts

30,000+ verified contacts

BiotechnologyForestryLife ScienceNatural Resources

Living Carbon is a public benefit company on a mission to fight climate change by genetically enhancing CO2 capture and storage in trees.

San Francisco, United States
April 2026
$21.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMachine LearningRoboticsTherapeutics

LabGenius uses a machine learning-driven evolution engine to develop protein therapeutics.

London, United Kingdom
February 2026
$64K
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedicalTherapeutics

Pendulum Therapeutics is a biotechnology firm improving health through products targeting the microbiome.

San Francisco, United States
February 2024
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth Care

Juvena Therapeutics is a biopharmaceutical platform which is discovering novel protein-based therapeutics.

Palo Alto, United States
July 2025
$30.5M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsLife ScienceOncologyPharmaceutical

Xilis is an oncology and precision health company that provides technologies to diagnoses cancer.

Durham, United States
April 2025
$19.4M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyFertilityHealth Care

Overture Life is a biotechnology company that develops automated technologies for assisted reproductive procedures.

Alcobendas, Spain
April 2025
$20.6M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedicalWellness

Granza Bio is a company that developing cancer therapies based on human body's immune system.

San Francisco, United States
July 2024
$7.1M
Seed

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyNeuroscienceTherapeutics

Reservoir Neuroscience is a biopharma company that develops novel therapeutics.

Emeryville, United States
January 2024
$4.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Dnovobio is a developer of a direct reprogramming technology intended to create any cell, tissue, or organ on demand.

San Jose, United States
January 2022
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Hepta Bio detect, monitor, and direct the most effective liver treatment.

San Francisco, United States
November 2025
$6.7M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyFood and BeverageHealth Care

Supplant is a biotechnology platform that makes sugar substitutes.

Cambridge, United Kingdom
October 2021
$18.0M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife ScienceTherapeutics

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

Richmond, United States
January 2026
$115.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth Diagnostics

Clear Labs is a biotechnology firm that integrates a genomics system to simplify diagnostics for the clinical and application sectors.

San Carlos, United States
January 2025
$30.0M
Series D

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyClinical TrialsHealth CareMedicalPharmaceutical

Formation Bio is a drug development company that strives to provide treatments to patients faster by reimagining clinical trials.

New York, United States
June 2024
$372.0M
Series D

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareLife SciencePharmaceutical

Spring Discovery accelerates the discovery of therapies for aging by targeting the biological processes of aging itself.

Palo Alto, United States
January 2021
Series B

Founder Contacts

30,000+ verified contacts

Explore Felicis's Full Portfolio

View all companies funded by Felicis across every industry and funding stage.

View Full Felicis Portfolio